PHILADELPHIA – Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy)...
PHILADELPHIA – Younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older...
10 members of the AACR elected, including Fellow of the AACR Academy Drew Pardoll, MD, PhD PHILADELPHIA – The...
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...
Patients with cancer may not receive full benefit of vaccination and are at higher risk for severe illness and...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) announced the creation of two career development awards (CDAs)...
Fifty years after the signing of the National Cancer Act, rapid progress against cancer for patients continues Medical research...
PHILADELPHIA — The American Association for Cancer Research (AACR) today expressed its gratitude to Francis S. Collins, MD, PhD,...
PHILADELPHIA – A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint...
PHILADELPHIA – In preclinical models, combining an investigational Aurora Kinase A (AURKA) inhibitor with a KRAS inhibitor or a...